Effect | Increase |
Trial Design | Double blind |
Trial Length | 2-4 Weeks |
Number of Subjects | 61 |
Sex | Both Genders |
Age Range | 18-29, 30-44, 45-64 |
In 61 persons with non-psychotic anxiety, Kava was more effective than placebo at improving sleep (both quality and recuperative effects) and reducing anxiety at 200mg of WS 1490 daily over 4 weeks